Finland Cardiovascular Drug Industry Outlook 2022 - 2026

See how Finland Cardiovascular Drug performed compared to key markets such as Germany, Italy and Canada.

Key Market Indicators

Sales of beta blocking medicines in Finland are projected to decline from $24.09 million this year to around $18.6 million in 2026. Since 2003, the Finnish market has decreased by an average rate of 3.6% annually. Slovakia was the leader in 2021 with total sales of $24.09 million. Italy, Canada, and Australia followed in second, third, and fourth place respectively.

Finland Cardiovascular Drug Market Data and Forecasts

Finland Cardiovascular Drug : how will it grow in the coming years?

Forecast: Antiarrhythmic Medicine Sales in Finland
Forecast: Antihypertensive Medicine Sales in Finland
Forecast: Cardiac Glycosides Sales in Finland
Forecast: Beta Blocking Medicine Sales in Finland
Forecast: Diuretic Medicine Sales in Finland
Forecast: Cardiac Glycosides Sales in Finland
Forecast: Antihypertensive Medicine Sales in Finland
Forecast: Beta Blocking Medicine Sales in Finland

Other Top Countries about Cardiovascular Drug